只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-08 2026-07-09 | CVSA Covista Inc. | Phelan Robert J. Officer · Chief Financial Officer | 卖出（S） | 2,414 | US$135.39 | US$326,821.80 | 50,492 | SEC |
| 2026-07-07 2026-07-09 | CVSA Covista Inc. | BECK DOUGLAS G. Officer · SVP, GC, Corp. Sec & ISS | 卖出（S） | 2,650 | US$135.40 | US$358,817.95 | 35,509 | SEC |
| 2026-07-07 2026-07-09 | CVSA Covista Inc. | Phelan Robert J. Officer · Chief Financial Officer | 卖出（S） | 2,900 | US$135.41 | US$392,677.40 | 52,906 | SEC |
| 2026-06-11 2026-06-12 | CVSA Covista Inc. | Beard, Stephen W. Officer · Chairman & CEO | 卖出（S） | 2,529 | US$130.78 | US$330,742.62 | 424,033 | SEC |
| 2026-06-10 2026-06-12 | CVSA Covista Inc. | Beard, Stephen W. Officer · Chairman & CEO | 卖出（S） | 2,762 | US$130.14 | US$359,446.68 | 426,562 | SEC |
| 2026-05-21 2026-05-21 | CVS CVS HEALTH Corp | ROBBINS LARRY Director | 卖出（S） | 370,462 | US$93.45 | US$3461.97万 | 4,824,799 | SEC |
| 2026-05-20 2026-05-21 | CVS CVS HEALTH Corp | ROBBINS LARRY Director | 卖出（S） | 66,881 | US$95.67 | US$639.85万 | 5,196,061 | SEC |
| 2026-05-20 2026-05-21 | CVS CVS HEALTH Corp | ROBBINS LARRY Director | 卖出（S） | 800 | US$96.28 | US$77,024.00 | 5,195,261 | SEC |
| 2026-05-20 2026-05-21 | CVS CVS HEALTH Corp | ROBBINS LARRY Director | 卖出（S） | 797,628 | US$93.48 | US$7456.23万 | 5,415,633 | SEC |
| 2026-05-20 2026-05-21 | CVS CVS HEALTH Corp | ROBBINS LARRY Director | 卖出（S） | 152,691 | US$94.81 | US$1447.66万 | 5,262,942 | SEC |
| 2026-05-19 2026-05-21 | CVS CVS HEALTH Corp | ROBBINS LARRY Director | 卖出（S） | 1,983,387 | US$94.45 | US$1.87亿 | 6,213,412 | SEC |
| 2026-05-19 2026-05-21 | CVS CVS HEALTH Corp | ROBBINS LARRY Director | 卖出（S） | 151 | US$95.18 | US$14,372.18 | 6,213,261 | SEC |
| 2026-05-08 2026-05-12 | CVSA Covista Inc. | Beard, Stephen W. Officer · Chairman & CEO | 卖出（S） | 15,874 | US$131.25 | US$208.35万 | 429,324 | SEC |
| 2026-05-08 2026-05-12 | CVSA Covista Inc. | Cox Karen Sue Officer · President, Chamberlain Univ. | 卖出（S） | 2,000 | US$124.50 | US$249,000.00 | 31,596 | SEC |
| 2026-05-08 2026-05-12 | CVSA Covista Inc. | BECK DOUGLAS G. Officer · SVP, GC, Corp. Sec & ISS | 卖出（S） | 9,615 | US$127.03 | US$122.14万 | 38,159 | SEC |
| 2026-05-08 2026-05-12 | CVSA Covista Inc. | Phelan Robert J. Officer · Chief Financial Officer | 卖出（S） | 10,000 | US$126.21 | US$126.21万 | 55,806 | SEC |
| 2026-05-08 2026-05-11 | CVS CVS HEALTH Corp | Mandadi Tilak Officer · EVP, Chief Exp & Tech Officer | 卖出（S） | 69,551 | US$89.58 | US$623.04万 | 10,133 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| CVSB | 8,859.952 | 0 | 11,227.5727 | 78.91% | Q |
| CVSA | 73,424.1087 | 0 | 144,295.2139 | 50.88% | Q, N |
| CVSM | 3 | 0 | 6 | 50.00% | Q |
| CVS | 672,585.9039 | 21,330 | 1,738,320.1483 | 38.69% | B, Q, N |